Belinostat exerts antitumor cytotoxicity through the ubiquitin‐proteasome pathway in lung squamous cell carcinoma

There have been advances in personalized therapy directed by molecular profiles in lung adenocarcinoma, but not in lung squamous cell carcinoma (SCC). The lack of actionable driver oncogenes in SCC has restricted the use of small‐molecule inhibitors. Here, we show that SCC cell lines displayed diffe...

Descripción completa

Detalles Bibliográficos
Autores principales: Kong, Li R., Tan, Tuan Z., Ong, Weijie R., Bi, Chonglei, Huynh, Hung, Lee, Soo C., Chng, Wee J., Eichhorn, Pieter J. A., Goh, Boon C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5537703/
https://www.ncbi.nlm.nih.gov/pubmed/28397399
http://dx.doi.org/10.1002/1878-0261.12064

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5537703/
https://www.ncbi.nlm.nih.gov/pubmed/28397399
http://dx.doi.org/10.1002/1878-0261.12064

Ejemplares similares